A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study

Summary

The purpose of the study is to evaluate long-term safety and tolerability of continuous treatment with ASP8273 in subjects who are participating in an Astellas-sponsored ASP8273 study which has completed, at a minimum, the primary analysis or have completed the individual study evaluation period and for whom the investigator feels the subject may have potential to continue to derive clinical benefit from treatment with ASP8273.

Timeline

Start

2017-02-28

Primary completion

2017-02-28

Completion

2017-02-28

Drugs

Indications